Device / Technology News

RSS

First heart surgery using MECC system completed

MAQUET Cardiovascular announced today that Johannes Bonatti, M.D., Professor of Surgery and Director of Coronary Surgery and Advanced Coronary Interventions at the University of Maryland Heart Center in Baltimore, has completed the world's first use of the MAQUET Minimized ExtraCorporeal Circulation (MECC) system during a successful robotic and fully endoscopic heart surgery. The new cardiopulmonary bypass technology is the first major advancement in perfusion technology in the last decade. It is designed to minimize the effects of traditional heart surgery and aid in minimally-invasive heart surgery without the need to stop the patient's heart from beating.

28 Sep 2009

S&P Consultants and Vedant collaborate to increase patient safety in Cerner Millennium implementations

A new business partnership of S&P Consultants, Inc. and Vedant Incorporated will now offer the highest levels of quality- and patient-safety assurance to both standard and customized applications built on the Cerner Millennium® platform. Both companies have particular expertise in the Cerner Millennium® environment, with S&P providing a broad range of consulting services and Vedant offering TestStream®, a comprehensive suite of software testing and validation solutions for systems of all levels of complexity and scale.

26 Sep 2009

Network in Canada to develop biomaterials for treatment of eye diseases

Researchers in Canada have established a new university/industry network to pursue the development of biomaterials, medical devices and drug delivery systems to treat the increasing incidence of eye disease.

26 Sep 2009

ProSperus, Genesis Physicians Group launch GenPro Practice Management Solutions

ProSperus, a Mequon, Wis.,-based, full-service practice management company, and Genesis Physicians Group, a Dallas-based independent physicians association (IPA), today announced the launch of GenPro Practice Management Solutions.

26 Sep 2009

Sonomax signs five year licensing agreement with Dutch company

Sonomax Hearing Healthcare Inc. (TSX Venture: SHH) announces that it has signed a five year licensing agreement with a newly formed Dutch company which has adopted the name Sonomax Europe BV (hereafter SEBV) with Sonomax's approval. Sonomax is not a stakeholder in SEBV.

26 Sep 2009

NSF funds UAB to purchase highly-specialized imaging system

The National Science Foundation has awarded $431,200 to the University of Alabama at Birmingham (UAB) Department of Physics to facilitate the purchase of a new highly-specialized imaging system - the first of its kind in Alabama - that will be a centerpiece of a new interdisciplinary research laboratory on campus.

26 Sep 2009

Initial clinical results for Mpathy Medical's Omnisure sling released

Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of less invasive surgical solutions used to restore pelvic health to women, released the initial clinical results for its newest product, Omnisure™, a novel full length sling for treatment of female stress urinary incontinence (SUI) at the American Urogynecologic Society’s (AUGS) Annual Meeting.

26 Sep 2009

PureSafety's OHM solutions at Salem Hospital

Salem Hospital, a 464-acute care non-profit hospital that operates the busiest emergency department in Oregon, has partnered with PureSafety to utilize the company’s Occupational Health Manager® (OHM) solutions to streamline the hospital’s occupational health and medical management processes.

26 Sep 2009

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the administration of the anticoagulant medication bivalirudin enhanced safety and efficacy compared to the use of heparin + GPIIb/IIIa inhibitors.

25 Sep 2009

RXi Pharmaceuticals acquires self-delivering rxRNA technology platform from Advirna

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has recently acquired direct ownership of technology for which it had previously exercised its option to exclusively license from Advirna LLC.

25 Sep 2009

Jazz Semiconductor offers its Reliability Modeling Tool for high reliability applications in medical markets

Jazz Semiconductor, Inc., a Tower Group Company, today announced its pioneering Reliability Modeling Tool (RMT), offered free to its customers through its eBizz Web portal. The tool is critical for high reliability applications in aerospace, defense, automotive and medical markets.

25 Sep 2009

Levin Group to develop a practice integration program for BIOLASE dental lasers

BIOLASE Technology, Inc. today announced that it has engaged Baltimore-based Levin Group, Inc., a leading international dental practice consulting firm, to develop a practice management system for the successful integration and implementation of BIOLASE dental lasers into everyday dental offices.

25 Sep 2009

ethica Clinical Research, Matrix Pharma sign worldwide agreement

ethica Clinical Research Inc. ("ethica"), a Contract Research Organization (CRO) headquartered in Montreal, and Matrix Pharma Canada Inc. ("Matrix Pharma"), have announced the signing of an agreement, valued at CAD1.25 Million, that provides ethica with an exclusive, worldwide license to promote and use Matrix Pharma's proprietary research data analysis technology for life sciences applications, notably for the identification and optimization of biomarkers.

25 Sep 2009

UHP's electronic health record system recognized

Urban Health Plan in the South Bronx is revolutionizing the way patients are identified and tracked at their network of community health centers. From identifying patients through an iris recognition scan to managing their patients' health through a fully electronic system, UHP is able to provide state-of-the-art, quality and comprehensive care to thousands of New York's neediest residents. This week, their efforts were recognized by the Healthcare Information and Management Systems Society who awarded them the 2009 HIMSS Davies Award of Excellence. Urban Health Plan uses eClinicalWorks (ECW) as its electronic health record (EHR) system.

25 Sep 2009

Cynosure to market Smartlipo MPX LaserBodySculpting Workstation in Korea

Broadening the reach of two of its flagship aesthetic laser products into the Asia Pacific region, Cynosure, Inc. today announced that it has received approval to market the Smartlipo MPX(TM) LaserBodySculpting(SM) Workstation in Korea and the Affirm(TM) Anti-Aging Workstation in the People's Republic of China.

25 Sep 2009

Caliper Life Sciences unveils XenoLight Rediject reagents series at WMIC

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.

25 Sep 2009

The Adiana permanent contraception system supported by UK's NICE

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the United Kingdom's National Institute for Health and Clinical Excellence (NICE), in its updated guidance for hysteroscopic sterilization, supports the use of Hologic's Adiana((R)) permanent contraception system.

25 Sep 2009

Versa Card opens the first spine treatment center in Houston

Versa Card, Inc., doing business as "Spine Pain Management, Inc." (the "Company"), is pleased to announce that the first spine treatment center has opened in Houston, Texas.

25 Sep 2009

FDA provides a conditional approval for Reverse Medical Corporation's ReStore Microcatheter IDE study

Reverse Medical Corporation announced today that it has received US Food and Drug Administration (FDA) conditional approval to begin a neurothrombectomy IDE study for its ReStore™ Microcatheter at twenty US centers. The study is planned to begin enrollment in US and European hospitals following investigating study center Institutional Review Board (IRB) approvals.

25 Sep 2009

Collaboration for the evaluation of peptide copolymer technology

Peptimmune, Inc., a privately held biotechnology company announced today that it has formed a research and development collaboration with the Walter Reed Army Institute of Research (WRAIR) and the Naval Medical Research Center (NMRC), Silver Spring, MD to evaluate the Company's proprietary DEEP(TM) peptide copolymer technology for the potential development of dengue vaccines and point-of-care diagnostics.

25 Sep 2009